UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...

With over 168 million views and counting, this CoComelon video follows JJ and his friends as they count the ten adorable baby ...

UCB enters agreement to acquire Candid Therapeutics in a deal worth up to $2.2 billion, adding BCMA-targeting T-cell engager ...

UCB to buy clinical-stage biotech company, Candid Therapeuticsfor US$ 2.2 billion: Brussels, Belgium Tuesday, May 5, 2026, 09:00 Hrs [IST] UCB, a global biopharmaceutical company, ...

Time for a new family hauler? We compare seven of the leading candidates—Dodge Stratus, Ford Contour, Honda Accord, Mazda 626 ...

Rothblatt connected those programs to longer-term scale, stating, "Each of the 2 products will exceed our total revenues of today, a revenue run rate of $3 billion going to $4 billion by the end of ...

UCB, a global biopharmaceutical company, today (May 3rd) announced signing of a definitive agreement under which it would ...

Warner Music Group Corp. ( WMG) Q2 2026 Earnings Call May 7, 2026 4:30 PM EDT ...

Music supervisor Frederic Schindler argues it’s time for standardized ‘Music Facts’ labels – modeled on food nutrition panels ...

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

Initial CX-801 clinical data in advanced melanoma, both as monotherapy and in combination with KEYTRUDA, are expected by the end of 2026, with observed tolerability at doses surpassing the approved ...

After the US$37 billion, 300-plane deal from Trump's last visit stalled, industry observers say the next one could be more ...